Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.
about
Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brainAre cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyondAdditive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activityAltered mRNA editing and expression of ionotropic glutamate receptors after kainic acid exposure in cyclooxygenase-2 deficient mice.Diverse methyl sulfone-containing benzo[b]thiophene library via iodocyclization and palladium-catalyzed coupling.Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancerConstitutive expression of prostaglandin-endoperoxide synthase 2 by somatic and spermatogenic cells is responsible for prostaglandin E2 production in the adult rat testis.Therapeutic potential of a non-steroidal bifunctional anti-inflammatory and anti-cholinergic agent against skin injury induced by sulfur mustard.NMDA-induced seizure intensity is enhanced in COX-2 deficient mice.Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination.The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension.Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice.Alterations in oxidative, inflammatory and apoptotic events in short-lived and long-lived mice testesAltered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient miceInflammation and lung carcinogenesis: applying findings in prevention and treatment.PET imaging of inflammation biomarkers.Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment.Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive reviewProstate Cancer and Aspirin Use: Synopsis of the Proposed Molecular MechanismsIdentification of a radical formed in the reaction mixtures of ram seminal vesicle microsomes with arachidonic Acid using high performance liquid chromatography-electron spin resonance spectrometry and high performance liquid chromatography-electronInhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step.COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression.Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress.The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.Increased COX2 in the trigeminal nucleus caudalis is involved in orofacial pain induced by experimental tooth movement.Cyclo-oxygenase-2 inhibition and exacerbation of myocardial dysfunction--protection with nitric oxide?Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.Pharmacodynamics and enantioselective pharmacokinetics of racemic carprofen in the horse.The effects of alpha-viniferin on adjuvant-induced arthritis in rats.A2E selectively induces cox-2 in ARPE-19 and human neural cells.Differential effects of docoosahexaenoic and arachidonic acid on fatty acid composition and myosin heavy chain-related genes of slow- and fast-twitch skeletal muscle tissues.The effect of age on prostaglandin-synthesizing enzymes in the development of gingivitis.
P2860
Q21184137-051AF151-3426-4809-8637-BE58F65BE244Q27324133-0B53DF4B-DFCB-4F77-AC80-A204B9D665D2Q28210656-FD6F9FE4-8BF2-4825-9FF0-A76419234E75Q28219414-6ABDFAE5-1FF1-48CC-B52B-E6E0732BDCB4Q31010610-44FC06DC-7154-4F10-B05C-41FA6141A9DCQ33522431-FC2467BF-4644-459E-B0D3-72B3ADB12401Q33624653-279059B0-BBD2-4A8E-AE7B-4910DD8FC222Q33933054-0C1CE6C6-404D-4595-A7DC-C5FEC83113D7Q34128977-5AD458D4-C494-4B4D-913D-727EFC449186Q34605958-1699007B-B70D-4B29-8DA5-2519C18D6EF8Q34624283-DD7CF7A7-2767-448D-AD26-513144F49EEDQ34845028-601D6E11-E508-48FE-B501-9D0FEBF7E702Q35028003-B8690DFB-F727-46A6-ADCF-56B7D96D4D6CQ35081897-3AF1D12E-771D-40F2-B90E-1B2A1C5D2637Q35132201-26E99F45-0057-4051-9342-87D4351A2C8CQ35176262-5B199419-6FE4-4893-AEE6-3F4F40FFD0A7Q36155297-D965186E-5806-49EA-A3D6-A45AD0EA56C4Q36601662-525FD34F-3C30-460E-8893-D3400B0D86E8Q36711212-7696D79D-C441-4523-83DC-5655F3E22156Q36974700-F36574B1-E5EE-4E94-AFFA-5B41FA1BA252Q36997603-EC8855B5-95D0-40A0-9B91-81DEE7EA3C1FQ37096361-37753EE0-4F16-45EF-9C51-1322A9299559Q38622919-4BEB1FC0-E011-49BE-9B38-3803B6872499Q38854428-267E0FB3-CEF7-4B74-B5A1-617E6E63C853Q39366145-A5373379-9E46-4610-88AB-2274D7370278Q39959950-508CA71D-0201-4F11-8957-2D35870C6B7FQ40173450-004DADCA-3EB5-42B5-9D84-8FC52355E647Q41442524-022E61AD-F7EB-4294-975E-1D1CEA1C6AD6Q42419278-6F87C96D-BD10-493C-A296-DA41CE7BD5ADQ43187338-EDE54C85-C225-4105-981E-CC1640A864BFQ43263866-CCF02F01-9E96-4941-A6EC-BDBD98B2BB44Q44126256-93E887D8-7DD5-4902-BA20-809D8AD133FEQ44251219-754489D0-CDD6-4054-9BEB-337837C2178AQ45104630-D880CFF1-28B9-4B2E-BCD0-218C65087522Q46986512-8DDE92B5-0A23-4CB2-96C4-45572B02D2EBQ50525039-5EF6A409-F700-444E-8AFE-08CEEE417193Q53557973-107E6AD6-6649-4D5A-8EDB-61E2D7C83ADF
P2860
Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@ast
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@en
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@nl
type
label
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@ast
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@en
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@nl
prefLabel
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@ast
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@en
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@nl
P356
P1476
Cyclooxygenase-2: its rich div ...... n of its selective inhibitors.
@en
P2093
P2888
P304
P356
10.1007/S000110050605
P577
2000-08-01T00:00:00Z
P6179
1027069924